The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was estimated at US$ 3.8 billion in 2021 and is predicted to reach US$ 5.5 billion by 2030, according to a new market analysis conducted by Future Market Insights (FMI). Among the serious illnesses brought on by Staphylococcus aureus germs include sepsis, toxic shock syndrome, bacteremia, osteomyelitis, …
Category Archives: Healthcare Trends
Respiratory Pathogen Testing Kits Market is expected to surpass US$ 7,136.8 million a CAGR of 5.7% through 2033
The global Respiratory Pathogen Testing Kits Market is anticipated to grow at a CAGR of 5.7% from 2023 to 2033, according to the most recent market research study by FMI. The market is anticipated to grow to a value of US$ 4083 million in 2023. The worth is predicted to reach US$ 7136.8 million by …
Japan’s Pneumococcal Testing Market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 9.8% CAGR from 2022 to 2030
The Global Pneumococcal Testing Market is expected to reach US$ 3.6 billion by 2030, according to a recent industry study by Future Market Insights (FMI). The market is currently estimated to be worth US$ 1.6 billion in 2022. Due to its present diagnostic landscape, which includes unmet needs and rising technology, pneumococcal testing is becoming …
Non-opioid Pain Patches Market is Expanding at a healthy 4.1% CAGR, the size is projected to total US$ 4.4 Billion by 2029
Sales of Non-opioid Pain Patches Market are projected to total US$ 3.3 billion in 2022. The market is anticipated to reach US$ 4.4 billion by 2029, expanding at a strong 4.1% CAGR. Due to the potential for addiction and safety concerns associated with alternative opioid pain relievers, non-opioid pain patches have recently attracted the interest …
Preterm Birth Prevention and Management Market is forecast to register a CAGR of 10.1% between 2022 and 2029
In 2022, the Preterm Birth Prevention and Management Market is anticipated to be valued roughly US$1.41 billion. Preterm birth prevention and management treatments are becoming more widely used in both developed and developing nations, and it is predicted that between 2022 and 2029, the global market will expand at a CAGR of 10.1%, reaching a …
Generic Injectable Market is projected to reach a valuation of US$ 3,22,433.1 million by 2033 record a CAGR of 11.6%
The Generic Injectable Market is anticipated to reach US$ 3,22,433.1 million in value by 2033, expanding at a CAGR of 11.6% from 2023 to 2033. In 2023, it is projected that the market will be worth US$ 1,07,419.72 million. The global market for generic injectables is anticipated to reach US$ 85 billion in 2021, according …
Animal Artificial Insemination Market is expected to surpass US$ 3.6 Billion and grow at 5.5% CAGR through 2032
The Animal Artificial Insemination Market is anticipated to surpass US$2.11 billion in 2022. The artificial insemination market for animals is projected to grow to more than US$3.6 billion by 2032. The market for animal artificial insemination is anticipated to grow at a CAGR of 5.5% from 2018 to 2032. The market for animal artificial insemination …
Corneal Ulcer Treatment Market is expected to reach US$ 1.27 Billion by end of 2029 at a CAGR of 5.7%
The Corneal Ulcer Treatment Market is anticipated to develop as a result of rising contact lens usage, novel treatment options, such as anti-amoebic medications, and well-established supply chain operations. The market for corneal ulcer therapy is expected to grow significantly at 5.7% CAGR from 2022 to 2029, reaching an estimated market value of about US$ …
Japan’s Veterinary Biologics Market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.8% CAGR from 2022 to 2029
A recent market analysis by Future Market Insights (FMI) projects that the global Veterinary Biologics Market will be worth US$ 11.4 billion in 2022 and US$ 18.2 billion by 2029. Pet health concerns are on the rise due to the growing trend of pet ownership around the world, which is driving up demand for veterinary …
Therapeutic Nuclear Medicines Market is projected to increase from a valuation of US$ 1 Billion in 2022 | FMI
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor in encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendations owing to no proven significant adverse effects. In the backdrop of the growing criticality of a more reliable, safer, and lesser …